Mindfulness based stress reduction study design of a longitudinal randomized controlled complementary intervention in women with breast cancer

Elisabeth Kenne Sarenmalm, Lena B Mårtensson, Stig B Holmberg, Bengt A Andersson, Anders Odén, Ingrid Bergh, Elisabeth Kenne Sarenmalm, Lena B Mårtensson, Stig B Holmberg, Bengt A Andersson, Anders Odén, Ingrid Bergh

Abstract

Background: The stress of a breast cancer diagnosis and its treatment can produce a variety of psychosocial sequelae including impaired immune responses. Mindfulness Based Stress Reduction (MBSR) is a structured complementary program that incorporates meditation, yoga and mind-body exercises. Despite promising empirical evidence for the efficacy of MBSR, there is a need for randomized controlled trials (RCT). There is also a need for RCTs investigating the efficacy of psychosocial interventions on mood disorder and immune response in women with breast cancer. Therefore, the overall aim is to determine the efficacy of a Mindfulness Based Stress Reduction (MBSR) intervention on well-being and immune response in women with breast cancer.

Methods and design: In this RCT, patients diagnosed with breast cancer, will consecutively be recruited to participate. Participants will be randomized into one of three groups: MBSR Intervention I (weekly group sessions + self-instructing program), MBSR Intervention II (self-instructing program), and Controls (non-MBSR). Data will be collected before start of intervention, and 3, 6, and 12 months and thereafter yearly up to 5 years. This study may contribute to evidence-based knowledge concerning the efficacy of MBSR to support patient empowerment to regain health in breast cancer disease.

Discussion: The present study may contribute to evidence-based knowledge concerning the efficacy of mindfulness training to support patient empowerment to regain health in a breast cancer disease. If MBSR is effective for symptom relief and quality of life, the method will have significant clinical relevance that may generate standard of care for patients with breast cancer.

Trial registration: ClinicalTrials.gov: NCT01591915.

Figures

Figure 1
Figure 1
Study design including enrollment, allocation and follow-up. MBSR = Mindfulness Based Stress Reduction.

References

    1. Morasso G, Costantini M, Viterbori P, Bonci F, Del Mastro L, Musso M, Garrone O, Venturini M. Predicting mood disorders in breast cancer patients. Eur J Canc. 2001;37(2):216–223. doi: 10.1016/S0959-8049(00)00390-7.
    1. Boehmke MM, Brown JK. Predictors of symptom distress in women with breast cancer during the first chemotherapy cycle. Can Oncol Nurs J. 2005;15(4):215–227. doi: 10.5737/1181912x154215220.
    1. Hjerl K, Andersen EW, Keiding N, Mortensen PB, Jorgensen T. Increased incidence of affective disorders, anxiety disorders, and non-natural mortality in women after breast cancer diagnosis: a nation-wide cohort study in Denmark. Acta Psychiatr Scand. 2002;105(4):258–264. doi: 10.1034/j.1600-0447.2002.9028.x.
    1. Maguire P. Managing psychological morbidity in cancer patients. Eur J Canc. 2000;36(5):556–558.
    1. Bleiker EM, Pouwer F, van der Ploeg HM, Leer JW, Ader HJ. Psychological distress two years after diagnosis of breast cancer: frequency and prediction. Patient Educ Counsel. 2000;40(3):209–217. doi: 10.1016/S0738-3991(99)00085-3.
    1. Carver CS, Pozo C, Harris SD, Noriega V, Scheier MF, Robinson DS, Ketcham AS, Moffat FL Jr, Clark KC. How coping mediates the effect of optimism on distress: a study of women with early stage breast cancer. J Pers Soc Psychol. 1993;65(2):375–390.
    1. Epping-Jordan JE, Compas BE, Osowiecki DM, Oppedisano G, Gerhardt C, Primo K, Krag DN. Psychological adjustment in breast cancer: processes of emotional distress. Health Psychol. 1999;18(4):315–326.
    1. Andrykowski MA, Curran SL, Studts JL, Cunningham L, Carpenter JS, McGrath PC, Sloan DA, Kenady DE. Psychosocial adjustment and quality of life in women with breast cancer and benign breast problems: a controlled comparison. J Clin Epidemiol. 1996;49(8):827–834. doi: 10.1016/0895-4356(96)00028-5.
    1. Cordova MJ, Cunningham LL, Carlson CR, Andrykowski MA. Posttraumatic growth following breast cancer: a controlled comparison study. Health Psychol. 2001;20(3):176–185.
    1. Kenne Sarenmalm E, Thoren-Jonsson AL, Gaston-Johansson F, Ohlen J. Making sense of living under the shadow of death: adjusting to a recurrent breast cancer illness. Qual Health Res. 2009;19(8):1116–1130. doi: 10.1177/1049732309341728.
    1. Moyer A, Salovey P. Psychosocial sequelae of breast cancer and its treatment. Ann Behav Med. 1996;18(2):110–125. doi: 10.1007/BF02909583.
    1. Chida Y, Hamer M, Wardle J, Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Prac Oncol. 2008;5(8):466–475. doi: 10.1038/ncponc1134.
    1. Andersen BL, Farrar WB, Golden-Kreutz D, Kutz LA, MacCallum R, Courtney ME, Glaser R. Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst. 1998;90(1):30–36. doi: 10.1093/jnci/90.1.30.
    1. Thornton LM, Andersen BL, Crespin TR, Carson WE. Individual trajectories in stress covary with immunity during recovery from cancer diagnosis and treatments. Brain Behav Immun. 2007;21(2):185–194. doi: 10.1016/j.bbi.2006.06.007.
    1. Wiltschke C, Krainer M, Budinsky AC, Berger A, Muller C, Zeillinger R, Speiser P, Kubista E, Eibl M, Zielinski CC. Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study. Br J Canc. 1995;71(6):1292–1296. doi: 10.1038/bjc.1995.250.
    1. Yamasaki S, Kan N, Harada T, Ichinose Y, Moriguchi Y, Li L, Sugie T, Kodama H, Satoh K, Ohgaki K. Relationship between immunological parameters and survival of patients with liver metastases from breast cancer given immuno-chemotherapy. Breast Canc Res Treat. 1993;26(1):55–65. doi: 10.1007/BF00682700.
    1. Rao VS, Dyer CE, Jameel JK, Drew PJ, Greenman J. Potential prognostic and therapeutic roles for cytokines in breast cancer (Review) Oncol Rep. 2006;15(1):179–185.
    1. Yokoe T, Iino Y, Morishita Y. Trends of IL-6 and IL-8 levels in patients with recurrent breast cancer: preliminary report. Breast Canc (Tokyo, Japan) 2000;7(3):187–190. doi: 10.1007/BF02967458.
    1. Bachelot T, Ray-Coquard I, Menetrier-Caux C, Rastkha M, Duc A, Blay JY. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br J Canc. 2003;88(11):1721–1726. doi: 10.1038/sj.bjc.6600956.
    1. Salgado R, Junius S, Benoy I, Van Dam P, Vermeulen P, Van Marck E, Huget P, Dirix LY. Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int J Canc. 2003;103(5):642–646. doi: 10.1002/ijc.10833.
    1. Fawzy FI, Fawzy NW, Arndt LA, Pasnau RO. Critical review of psychosocial interventions in cancer care. Arch Gen Psychiatr. 1995;52(2):100–113. doi: 10.1001/archpsyc.1995.03950140018003.
    1. Sheard T, Maguire P. The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta-analyses. Br J Canc. 1999;80(11):1770–1780. doi: 10.1038/sj.bjc.6690596.
    1. Chambless DL, Hollon SD. Defining empirically supported therapies. J Consult Clin Psychol. 1998;66(1):7–18.
    1. Luecken LJ, Compas BE. Stress, coping, and immune function in breast cancer. Ann Behav Med. 2002;24(4):336–344. doi: 10.1207/S15324796ABM2404_10.
    1. Kabat-Zinn J. Wherever you go, there you are: Mindfulness meditation for everyday life. London: Piatkus; 1994.
    1. Kabat-Zinn J, Massion AO, Kristeller J, Peterson LG, Fletcher KE, Pbert L, Lenderking WR, Santorelli SF. Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. J Am Psychiatr. 1992;149(7):936–943.
    1. Plews-Ogan M, Owens JE, Goodman M, Wolfe P, Schorling J. A pilot study evaluating mindfulness-based stress reduction and massage for the management of chronic pain. J Gen Intern Med. 2005;20(12):1136–1138. doi: 10.1111/j.1525-1497.2005.0247.x.
    1. Speca M, Carlson LE, Goodey E, Angen M. A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med. 2000;62(5):613–622.
    1. Baer RA. Mindfulness training as a clinical intervention: A conceptual and empirical review. Clin Psychol Sci Pract. 2003;10(2):125–143. doi: 10.1093/clipsy.bpg015.
    1. Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress reduction and health benefits. A meta-analysis. J Psychosom Res. 2004;57(1):35–43. doi: 10.1016/S0022-3999(03)00573-7.
    1. Lee SH, Ahn SC, Lee YJ, Choi TK, Yook KH, Suh SY. Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder. J Psychosom Res. 2007;62(2):189–195. doi: 10.1016/j.jpsychores.2006.09.009.
    1. Toneatto T, Nguyen L. Does mindfulness meditation improve anxiety and mood symptoms? A review of the controlled research. Can J Psychiatry Revue canadienne de psychiatrie. 2007;52(4):260–266.
    1. Witek-Janusek L, Albuquerque K, Chroniak KR, Chroniak C, Durazo-Arvizu R, Mathews HL. Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain Behav Immun. 2008;22(6):969–981. doi: 10.1016/j.bbi.2008.01.012.
    1. Branstrom R, Kvillemo P, Brandberg Y, Moskowitz JT. Self-report mindfulness as a mediator of psychological well-being in a stress reduction intervention for cancer patients–a randomized study. Ann Behav Med. 2010;39(2):151–161. doi: 10.1007/s12160-010-9168-6.
    1. Branstrom R, Kvillemo P, Akerstedt T. Effects of mindfulness training on levels of cortisol in cancer patients. Psychosomatics. 2013;54(2):158–164. doi: 10.1016/j.psym.2012.04.007.
    1. Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med. 2003;65(4):571–581. doi: 10.1097/01.PSY.0000074003.35911.41.
    1. Carlson LE, Speca M, Faris P, Patel KD. One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain Behav Immun. 2007;21(8):1038–1049. doi: 10.1016/j.bbi.2007.04.002.
    1. Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology. 2004;29(4):448–474. doi: 10.1016/S0306-4530(03)00054-4.
    1. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche PC, Lang T, Consort G. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134(8):663–694. doi: 10.7326/0003-4819-134-8-200104170-00012.
    1. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D. group C. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. Bmj. 2008;337:a2390. doi: 10.1136/bmj.a2390.
    1. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, Group C. Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Ann Intern Med. 2008;148(4):W60–W66.
    1. SBU. Metoder för behandling av långvarig smärta: En systematisk litteraturöversikt. Stockholm: Statens beredning för medicinsk utvärdering; 2006.
    1. The Swedish Breast Cancer Group. National Guidelines. Breast Cancer Treatment. 2008. .
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Mykletun A, Stordal E, Dahl AA. Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population. Br J Psychiatry. 2001;179:540–544. doi: 10.1192/bjp.179.6.540.
    1. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale–a review of validation data and clinical results. J Psychosom Res. 1997;42(1):17–41. doi: 10.1016/S0022-3999(96)00216-4.
    1. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52(2):69–77. doi: 10.1016/S0022-3999(01)00296-3.
    1. Antonovsky A. Unraveling the mysteries of health: how people manage stress and stay well. San Francisco: Jossey-Bass; 1987.
    1. Antonovsky A. The structure and properties of the sense of coherence scale. Soc Sci Med. 1993;36(6):725–733. doi: 10.1016/0277-9536(93)90033-Z.
    1. Eriksson M, Lindstrom B. Validity of Antonovsky’s sense of coherence scale: a systematic review. J Epidemiol Community Health. 2005;59(6):460–466. doi: 10.1136/jech.2003.018085.
    1. Langius A, Bjorvell H, Antonovsky A. The sense of coherence concept and its relation to personality traits in Swedish samples. Scand J Caring Sci. 1992;6(3):165–171. doi: 10.1111/j.1471-6712.1992.tb00146.x.
    1. Gilbar O. Coping with threat. Implications for women with a family history of breast cancer. Psychosomatics. 1998;39(4):329–339. doi: 10.1016/S0033-3182(98)71321-0.
    1. Thome B, Hallberg IR. Quality of life in older people with cancer – a gender perspective. Eur J Canc Care. 2004;13(5):454–463. doi: 10.1111/j.1365-2354.2004.00471.x.
    1. Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L. et al.The memorial symptom assessment scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Canc. 1994;30A(9):1326–1336.
    1. Tranmer JE, Heyland D, Dudgeon D, Groll D, Squires-Graham M, Coulson K. Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale. J Pain Symptom Manag. 2003;25(5):420–429. doi: 10.1016/S0885-3924(03)00074-5.
    1. Hurny C, Bernhard J, Bacchi M, van Wegberg B, Tomamichel M, Spek U, Coates A, Castiglione M, Goldhirsch A, Senn HJ. et al.The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG) Support Care Cancer. 1993;1(4):200–208. doi: 10.1007/BF00366447.
    1. Bernhard J, Thurlimann B, Schmitz SF, Castiglione-Gertsch M, Cavalli F, Morant R, Fey MF, Bonnefoi H, Goldhirsch A, Hurny C. Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter? J Clin Oncol. 1999;17(6):1672–1679.
    1. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med care. 1994;32(1):40–66. doi: 10.1097/00005650-199401000-00004.
    1. Sullivan M, Karlsson J, Ware JE Jr. The Swedish SF-36 health survey--I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med. 1995;41(10):1349–1358. doi: 10.1016/0277-9536(95)00125-Q.
    1. Persson LO, Karlsson J, Bengtsson C, Steen B, Sullivan M. The Swedish SF-36 health survey II. Evaluation of clinical validity: results from population studies of elderly and women in Gothenborg. J Clin Epidemiol. 1998;51(11):1095–1103. doi: 10.1016/S0895-4356(98)00101-2.
    1. Sullivan M, Karlsson J. The Swedish SF-36 health survey III. Evaluation of criterion-based validity: results from normative population. J Clin Epidemiol. 1998;51(11):1105–1113. doi: 10.1016/S0895-4356(98)00102-4.
    1. Tedeschi RG, Calhoun LG. The posttraumatic growth inventory: measuring the positive legacy of trauma. J Trauma Stress. 1996;9(3):455–471. doi: 10.1002/jts.2490090305.
    1. Smith SG, Cook SL. Are reports of posttraumatic growth positively biased? J Trauma Stress. 2004;17(4):353–358. doi: 10.1023/B:JOTS.0000038485.38771.c6.
    1. Baer RA, Smith GT, Hopkins J, Krietemeyer J, Toney L. Using self-report assessment methods to explore facets of mindfulness. Assessment. 2006;13(1):27–45. doi: 10.1177/1073191105283504.
    1. Glaser B, Strauss A. The Discovery of Grounded Theory: Strategies for qualitative research. New York: Aldine de Gruyter; 1967.
    1. Glaser B. Theoretical sensitivity. Mill Valley, CA: Sociology Press; 1978.
    1. Personal Data Act. Swedish codes of statues. Min of Justice. 1998;1998:204.
    1. Biobanks in Medical Care Act. Swedish codes of statues. SFS. 2002;2002:297.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren